Elucidation of a novel mechanism of Benralizumab on human immune cells using humanized hIL-3/hGM-CSF/hIL-5 Tg NOG mice

S. Nunomura (Saga, Japan), R. Ito (Kawasaki, Japan), Y. Nanri (Saga, Japan), K. Izuhara (Saga, Japan)

Source: International Congress 2022 – Emerging therapeutic targets, biomarkers and mechanisms of chronic lung disease
Session: Emerging therapeutic targets, biomarkers and mechanisms of chronic lung disease
Session type: Thematic Poster
Number: 3566

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Nunomura (Saga, Japan), R. Ito (Kawasaki, Japan), Y. Nanri (Saga, Japan), K. Izuhara (Saga, Japan). Elucidation of a novel mechanism of Benralizumab on human immune cells using humanized hIL-3/hGM-CSF/hIL-5 Tg NOG mice. 3566

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.